Viva Biotech Holdings ("Viva Biotech") will hold a board of directors meeting on August 29, 2024 (Thursday) to consider and approve the interim performance report for the six months ended June 30, 2024, as well as its publication. The meeting will also consider whether to recommend the payment of interim dividends. The board of directors of Viva Biotech consists of three executive directors, two non-executive directors and three independent non-executive directors. The meeting will be presided over by Mr. Mao Chen, the Chairman and Chief Executive Officer of the company.

Viva Biotech Holdings ("Viva Biotech") will hold a board of directors meeting on August 29, 2024 (Thursday) to consider and approve the interim performance report for the six months ended June 30, 2024, as well as its publication. The meeting will also consider whether to recommend the payment of interim dividends. The board of directors of Viva Biotech consists of three executive directors, two non-executive directors and three independent non-executive directors. The meeting will be presided over by Mr. Mao Chen, the Chairman and Chief Executive Officer of the company.